COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,224 Articles (22,733 medRxiv, 8,491 bioRxiv)

Most recent first Previous |  Page 962: Articles 9611-9620  | Next

Evaluation of the CD4+ T cell response to SARS-CoV-2 infection and cross reactivity to beta variant in children of all ages
Paul, K., Sibbertsen, F., Weiskopf, D., Luetgehetmann, M., Barroso, M., Danecka, M. K., Glau, L., Hecher, L., Hermann, K., Kohl, A., Oh, J., Schulze zur Wiesch, J., Sette, A., Tolosa, E., Vettorazzi, E., Woidy, M., Zapf, A., Zazara, D. E., Mir, T. S., Muntau, A. C., Gersting, S. W., Dunay, G. A.
10.1101/2022.01.27.22269976 — Posted: 2022-01-28
Screening for SARS-CoV-2 in close contacts of individuals with confirmed infection: performance and operational considerations
Zobrist, S., Oliveira-Silva, M., Vieira, A. M., Bansil, P., Gerth-Guyette, E., Leader, B. T., Golden, A., Slater, H., Cruz, C. D. d. L., Garbin, E., Sagalovsky, M., Pal, S., Gupta, V., Wolansky, L., Dall Acqua, D. S. V., Naveca, F. G., Nascimento, V. A. d., Villalobos Salcedo, J. M., Drain, P. K., Costa, A. D. T., Domingo, G. J., Pereira, D.
10.1101/2022.01.27.22269904 — Posted: 2022-01-28
Analysis of Fatality Impact and Seroprevalence Surveys in a Community Sustaining a SARS-CoV-2 Superspreading Event
Richter, E., Liebl, D., Schulte, B., Lehmann, N., Fuhrmann, C., Joeckel, K.-H., Ioannidis, J., Streeck, H.
10.1101/2022.01.26.22269805 — Posted: 2022-01-28
SARS-CoV-2 in schools: genome analysis shows that concurrent cases in the second and third wave were often unconnected
Stange, M., Wuerfel, E., Peter, J. K., Seth-Smith, H., Roloff, T., Gsponer, S., Mari, A., Cabrera Gil, B., Lebrand, A., Wegner, F., Heininger, U., Bielicki, J., Tschudin Sutter, S., Stadler, T., Leuzinger, K., Hirsch, H. H., Ledergerber, M., Fuchs, S., Egli, A.
10.1101/2022.01.26.22269824 — Posted: 2022-01-28
Antibody and T cell responses to SARS-CoV-2 mRNA vaccines during maintenance therapy for immune-mediated inflammatory diseases
Dayam, R. M., Law, J. C., Goetgebuer, R. L., Chao, G. Y., Abe, K. T., Sutton, M., Finkelstein, N., Stempak, J. M., Pereira, D., Croituru, D., Acheampong, L., Rizwan, S., Rymaszewski, K., Milgrom, R., Ganatra, D., Batista, N. V., Girard, M., Lau, I., Law, R., Cheung, M. W., Rathod, B., Kitaygorodsky, J., Samson, R., Hu, Q., Haroon, N., Inman, R. D., Piguet, V., Chandran, V., Silverberg, M. S., Gingras, A.-C., Watts, T. H.
10.1101/2022.01.26.22269856 — Posted: 2022-01-28
General practitioner wellbeing during the COVID-19 pandemic: a qualitative interview study
Jefferson, L. A., Heathcote, C., Bloor, K.
10.1101/2022.01.26.22269874 — Posted: 2022-01-28
A model-based approach to improve intranasal sprays for respiratory viral infections
Basu, S., Akash, M. M. H., Lao, Y., Balivada, P. A., Ato, P., Ka, N. K., Mituniewicz, A., Silfen, Z., Suman, J., Chakravarty, A., Joseph-McCarthy, D.
10.1101/2022.01.26.22269854 — Posted: 2022-01-28
IMPACT OF WEEKNIGHT AND WEEKEND CURFEWS USING MOBILITY DATA: A CASE STUDY OF BENGALURU URBAN
Adiga, A., Athreya, S., Marathe, M., Midthala, J., Rathod, N., Sundaresan, R., Venkataramanan, S., Yasodharan, S.
10.1101/2022.01.26.22269903 — Posted: 2022-01-28
IRE1α-XBP1 Activation Elicited by Viral Singled Stranded RNA via TLR8 May Modulate Lung Cytokine Induction in SARS-CoV-2 Pneumonia
Fernandez, J. J., Mancebo, C., Garcinuno, S., March, G., Alvarez, Y., Alonso, S., Inglada, L., Blanco, J., Orduna, A., Montero, O., Sandoval, T. A., Cubillos-Ruiz, J. R., Bustamante, E., Fernandez, N., Sanchez Crespo, M.
10.1101/2022.01.26.22269752 — Posted: 2022-01-28
Endogenous pancreatic microRNAs differentially target the Delta, Omicron, and Wuhan SARS-CoV-2 genomes to upregulate the Diabetes-associated genes
Bhavya, B., Pathak, E., Mishra, R.
10.1101/2022.01.26.477612 — Posted: 2022-01-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).